Narrow search
Showing 1 - 10 of 555,998
Cover Image
Intellectual property marketplaces and how they work : evidence from German pharmaceutical firms
Andersen, Birgitte; Rossi, Federica; Stephan, Johannes - In: Intereconomics : review of European economic policy 45 (2010) 1, pp. 35-47
Persistent link: https://www.econbiz.de/10003931919
Cover Image
Intellectual property marketplaces and how they work : evidence from German pharmaceutical firms
Andersen, Birgitte; Rossi, Federica; Stephan, Johannes - In: Intereconomics : review of European economic policy 45 (2010) 1, pp. 35-47
This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...
Persistent link: https://www.econbiz.de/10009659550
Cover Image
Benefit assessment in Germany : implications for price discounts
Theidel, Ulrike; Schulenburg, Johann-Matthias von der - In: Health economics review 6 (2016) 33, pp. 1-12
Background: The AMNOG regulation, introduced in 2011 in Germany, changed the game for new drugs. Now, the industry is …
Persistent link: https://www.econbiz.de/10011586599
Cover Image
The diffusion of generics after patent expiry in Germany
Blankart, Katharina; Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 17 (2016) 8, pp. 1027-1040
Persistent link: https://www.econbiz.de/10011660160
Cover Image
Intellectual Property Marketplaces and How They Work : Evidence from German Pharmaceutical Firms
Andersen, Birgitte; Rossi, Federica; Stephan, Johannes … - 2014
This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...
Persistent link: https://www.econbiz.de/10014195216
Cover Image
Integrierte Versorgung und die Rolle der Pharmaindustrie
Koch, Kristian - 2009
Persistent link: https://www.econbiz.de/10003862841
Cover Image
Arzneimittel-Supply-Chain als Strategie begreifen: Optimierungsansätze aus der Sicht eines forschenden Arzneimittelherstellers
Getrost, Hans; Stratmann-Schöne, Diana - In: Arzneimittel-Supply-Chain : Marktsituation, aktuelle …, (pp. 153-163). 2009
Persistent link: https://www.econbiz.de/10003918837
Cover Image
Mehr Qualität und Wirtschaftlichkeit in der Arzneimittelversorgung durch neue Versorgungsstrukturen - von der Fiktion zur Realität?
Verheyen, Frank; Steimle, Tim; Schuber, Corinna; … - In: Arzneimittel-Supply-Chain : Marktsituation, aktuelle …, (pp. 303-316). 2009
Persistent link: https://www.econbiz.de/10003918872
Cover Image
Personalisierte Medizin als Innovationsstrategie der forschenden Pharmaindustrie für eine gesteigerte Effizienz in der Behandlung von Krankheiten
Pfundner, Hagen - In: Gesundheitssysteme im Wandel, (pp. 169-191). 2009
Persistent link: https://www.econbiz.de/10003921778
Cover Image
Healthcare RFID in Germany : an integrated pharmaceutical supply chain perspective
Chircu, Alina; Sultanow, Eldar; Saraswat, Satya Prakash - In: The journal of applied business research 30 (2014) 3, pp. 737-752
Persistent link: https://www.econbiz.de/10010370852